Damage-Associated Molecular Patterns Control Neutrophil Recruitment

Journal of Innate Immunity - Tập 5 Số 4 - Trang 315-323 - 2013
Keir Pittman1, Paul Kubes1
1Snyder Institute for Chronic Diseases and

Tóm tắt

Neutrophils are recruited to a site of infection or injury where they help initiate the acute inflammatory response. In instances of sterile inflammation, where no microbial threats are present, this neutrophil recruitment is mediated by the release of danger signals or damage-associated molecular patterns (DAMPs) from disrupted cells and tissues. At basal state, many of these substances are sequestered and remain hidden within the cell, but are released following the rupture of the plasma membrane. In other instances, these DAMPs are undetected by the innate immune system unless chemically or proteolytically modified by tissue damage. DAMPs may be directly detected by neutrophils themselves and modulate their recruitment to sites of damage or, alternatively, they can act on other cell types which in turn facilitate the arrival of neutrophils to a site of injury. In this review, we outline the direct and indirect effects of a number of DAMPs, notably extracellular ATP, mitochondrial formylated peptides and mitochondrial DNA, all of which are released by necrotic cells. We examine the effect of these substances on the recruitment and behaviour of neutrophils to sites of sterile injury. We also highlight research which suggests that neutrophils are actively involved in triggering the resolution phase of an inflammatory response. This review brings to light a growing body of work that demonstrates that the release of DAMPs and the ensuing influx of neutrophils plays an important functional role in the inflammatory response, even when no pathogens are present.

Từ khóa


Tài liệu tham khảo

10.1038/nri2156

10.1038/nri2532

10.1146/annurev.iy.12.040194.005015

10.1146/annurev-immunol-030409-101311

10.1038/nri2873

10.4049/jimmunol.0902485

10.1038/nm1603

10.4049/jimmunol.1200136

10.1111/j.1600-065X.2011.01040.x

10.1038/nature00858

10.1111/j.1365-2796.2003.01302.x

10.1016/S0092-8674(00)80801-6

10.1084/jem.20081370

10.1172/JCI35958

10.1016/j.immuni.2010.07.018

10.1126/science.1195491

10.1038/nn1472

10.1038/nature08296

10.1126/science.1132559

10.1073/pnas.0908698106

10.1126/science.283.5407.1476

10.1124/pr.109.001578

10.1084/jem.155.1.264

10.1002/eji.200526338

10.1097/BOT.0b013e3181ec4991

10.1097/TA.0b013e3181dcd28d

10.1016/j.injury.2009.07.010

10.1002/hep.25801

10.1002/eji.1830271016

10.1083/jcb.139.5.1349

10.1083/jcb.200202114

10.1038/jid.2011.179

10.1038/nature08780

10.1189/jlb.0703328

10.1016/j.immuni.2012.01.009

10.1016/j.immuni.2012.03.005

10.1038/nature10992

10.1038/sj.jid.5700811

10.1016/S0960-9822(03)00396-8

10.1073/pnas.0601807103

10.2337/db10-0205

10.1038/nri2779

10.2353/ajpath.2010.090527

10.1172/JCI30049

10.1038/nri2470

10.1182/blood-2005-08-3099